Breaking avelumab resistance with combined ipilimumab and nivolumab in metastatic Merkel cell carcinoma? [electronic resource]
Producer: 20200731Description: 1667-1668 p. digitalISSN:- 1569-8041
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Merkel Cell -- drug therapy
- Drug Resistance, Neoplasm -- drug effects
- Humans
- Ipilimumab -- administration & dosage
- Male
- Middle Aged
- Nivolumab -- administration & dosage
- Prognosis
- Skin Neoplasms -- drug therapy
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.